Long-Acting Injectable Risperidone Compared with Zuclopenthixol in the Treatment of Schizophrenia with Substance Abuse ComorbidityGabriel Rubio, Cecilio Álamo, Francisco López‐Muñoz et al.|The Canadian Journal of Psychiatry|2006Cited by 107